Financial statements Ferrosan Medical Devices
Balance sheet data of FERROSAN MEDICAL DEVICES
|
Year
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 21 088 878,70 | 20 369 018,02 | 17 136 124,69 | 31 328 206,25 | 34 722 588,52 |
| A. Fixed assets | 7 870 367,83 | 7 658 080,15 | 3 065 524,48 | 6 803 073,59 | 6 531 534,64 |
| B. Current assets | 13 218 510,87 | 12 710 937,87 | 14 070 600,21 | 24 525 132,65 | 28 191 053,87 |
| C. Share capital contributions (basic funds) | - | - | - | 0,00 | - |
| D. Own shares (stocks) | - | - | - | 0,00 | - |
| Total liabilities | 21 088 878,70 | 20 369 018,02 | 17 136 124,69 | 31 328 206,25 | 34 722 588,52 |
| A. Equity | 729 015,68 | 2 500 768,86 | 3 948 755,00 | 21 032 246,83 | 27 932 815,83 |
| B. Liabilities and provisions for liabilities | 20 359 863,02 | 17 868 249,16 | 13 187 369,69 | 10 295 959,42 | 6 789 772,70 |
| I. Long-term liabilities | - | - | - | - | 0,00 |
| II. Short-term liabilities | 19 208 258,57 | 15 673 728,35 | 11 051 102,60 | 8 263 035,31 | 4 535 642,19 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.